Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Brown Advisors Global Leaders Strategy 2023 Q2 Investor Letter | Buyside Digest

Back to Fund Profile (Brown Advisors Global Leaders Strategy)

Primary Source Intelligence • Q2 2023 Letter Analysis

Brown Advisors Global Leaders Strategy Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Brown Advisors Global Leaders Strategy. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

Annualized+11.7%

Positioning StanceConstructive

GeographyGlobal

Digest Analysis

Quick Take

"Concentrated global strategy investing in 30-40 market leaders with high returns on capital while actively managing factor risks. Recent AI-driven opportunities in Microsoft, Alphabet, and Marvell Technology."

Executive Summary

Brown Advisory's Global Leaders Strategy maintains a concentrated portfolio of 30-40 market-leading companies globally, focusing on businesses that deliver exceptional customer outcomes and generate high sustainable returns on invested capital. The managers emphasize rigorous factor risk management to ensure stock-specific selection drives performance rather than unintended sector, country, or style exposures. They use quantitative tools and weekly capital allocation meetings to monitor risks while maintaining their concentrated approach. The strategy has benefited from AI-related investments in Microsoft, Alphabet, and Marvell Technology, with the managers viewing technical infrastructure and semiconductor companies as having the highest probability AI opportunities. They maintain strict valuation discipline with minimum 10% WACC and double-digit IRR hurdle rates, recently finding more attractive opportunities in healthcare as valuations have declined. The portfolio currently has significant exposure to technology and financials sectors, though the managers view this as temporary based on the current opportunity set rather than a permanent structural bias.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

72%

CautiousHigh

High Conviction (72%)

High conviction evidenced by concentrated 30-40 position portfolio with named holdings and specific position sizing decisions. Microsoft described as 'biggest investment' and managers willing to add during weakness. Clear thesis per holding with specific IRR targets, though some hedging around AI outcomes prevents maximum score.

Growth Outlook

25%

BearishBullish

Bearish (25%)

The managers express cautious optimism about specific opportunities, particularly in AI and improving healthcare valuations, but maintain disciplined approach to valuation and acknowledge various market risks including factor exposures.

Risk Appetite

40%

DefensiveAggressive

Defensive (40%)

Portfolio remains concentrated with 30-40 positions and managers actively added to positions during weakness, but they also trimmed Alphabet after gains and maintain strict valuation discipline, indicating moderate risk appetite.

Capital Deployment

15%

De-riskingDeploying

De-risking (15%)

Mixed deployment activity with additions to Microsoft, Alphabet, and Marvell during weakness, but also trimming Alphabet after gains. No cash level changes mentioned. Activity appears to be rotation-based rather than net deployment, resulting in slightly positive but modest score.

Forward Guidance

30%

CautiousExpansionary

Cautious (30%)

Managers indicate selective deployment bias with improving healthcare opportunities and continued AI benefits, but emphasize patience and strict valuation hurdles, suggesting measured rather than aggressive deployment intentions.

Language Signal

20%

BearishBullish

Bearish (20%)

Language is balanced with opportunities mentioned (AI expansion, healthcare valuations improving) but significant discussion of risks, factor management, and need for discipline, resulting in slightly positive but cautious tone.

Perceived Risk

65%

Low RiskElevated

Elevated Risk (65%)

Substantial discussion of factor risks and their potential to overwhelm stock selection, plus detailed analysis of AI competitive risks. Managers devote significant attention to risk management tools and processes, indicating meaningful concern about various risk factors.

Opportunity Density

60%

ScarceAbundant

Selective (60%)

Managers see selective opportunities in AI infrastructure and improving healthcare valuations, but emphasize strict valuation discipline has caused them to pass on many otherwise attractive investments. Ready-to-Buy list mentioned but constrained by price discipline.

Time Horizon

70%

Short-TermLong-Term

Decade+ (70%)

Multi-year investment horizon evidenced by discussion of 5+ year investors, long-term holdings, and willingness to be patient on valuations. Focus on sustainable returns on capital and compound growth, though some catalyst dependency around AI development prevents higher score.